Coronavirus Screening Platform Uses Machine Learning Algorithms to Detect SARS-CoV-2 Structural Fingerprint in Real Time
A screening platform that can identify biological threats by shining a laser onto the sample and interpreting the light that scatters is being used to develop a coronavirus screening platform, according to a report by BioSpace. More...27 Aug 2020
Scientists Track Evolution of SARS-CoV-2 Virus Mutations to Expedite Development of COVID-19 Vaccines and Treatment
Researchers have been tracking the mutation rate in the novel coronavirus' proteome since the first SARS-CoV-2 genome was published in January in the hope that the exploration of mutational pathways can anticipate moving targets for speedy therapeutics and vaccine development. More...27 Aug 2020
Scientists Identify Five Drug Compounds That Completely Stop SARS-CoV-2 Replication by Interrupting Communication Pathways in Host Cells
Researchers have patented their technique of inhibiting cellular growth factor signaling to stop the SARS-CoV-2 from replicating and treat COVID-19, according to a report by Drug Target Review. More...27 Aug 2020
Sanofi’s COVID-19 Vaccine Generates Strong Antibody Response in Animals, Human Trials to Begin in November
Sanofi’s (Paris, France) experimental COVID-19 vaccine developed jointly with Translate Bio (Lexington, MA, USA) generated high amounts of protective neutralizing antibodies in early-stage animal studies. More...27 Aug 2020
Fluidigm’s Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay Secures FDA Emergency Use Authorization
Fluidigm Corporation (South San Francisco, CA, USA) has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for the Advanta Dx SARS-CoV-2 RT-PCR Assay, an extraction-free saliva-based test to detect nucleic acid from the SARS‑CoV‑2 virus. More...27 Aug 2020
UV-C LED Disinfection Robot Exterminates 99.9% of Live Human Coronavirus in Five Minutes
A UV-C LED disinfection robot that was tested in the laboratory using high concentrations of live samples of human coronavirus has achieved a 99.9% efficacy for disinfection within five minutes at a working distance of 2.5 meters. More...26 Aug 2020
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Medical-Grade POC Terminal
POC-821
New
Phototherapy Eye Protector
EyeMax2
In Other News
Nasal Spray for Protection Against COVID-19 Inhibits Infection of Host Cells by SARS‑CoV-2
AI Platform Repositions Drugs That Can Combat Blood Clotting and Inflammation in COVID-19 Patients
First-Ever Saliva-Based COVID and Influenza Combo Test to Screen for Coronavirus and Flu Infections
Inflammation Cytokine Markers Could Predict COVID-19 Severity and Survival
Cytokine Storms in COVID-19 Patients May Prevent Development of Long-Term Immunity to SARS-CoV-2 Virus
Study Finds Link Between Molecule in Fat Tissue and Severe COVID-19
Researchers Identify COVID Specific IgA Monoclonal Antibodies that Provide Immunity Against Novel Coronavirus
New COVID-19 Pooling Test Method Identifies Asymptomatic Carriers
Zymo Research’s Quick SARS-CoV-2 rRT-PCR Kit Receives CE-IVD Mark
Beckman Coulter Launches New SARS-CoV-2 Immunoglobulin M (IgM) Antibody Test
SARS-CoV-2 Acts as Sponge to Delete Specific Host microRNAs, Making it More Dangerous than Other Coronaviruses
FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment
Pfizer and BioNTech Release Positive Early Stage Data on mRNA COVID-19 Vaccine Trial
Johnson & Johnson to Begin Largest, Late-Stage 60,000 Person COVID-19 Vaccine Trial in September
New Transparent Facemask with Smart Capabilities Could Revolutionize COVID-19 Protection and Diagnostics
Gilead’s Remdesivir Might Not Be as Effective For 'Moderate' Cases of COVID-19, Finds New Study
Use of COVID-19 Tests without FDA Approval Could Bring New, Innovative Tests to Market More Quickly
OpGen Launches Own-Developed CE-IVD Marked Molecular Diagnostic SARS-CoV-2 Kit with PULB in Europe
AI-Driven Robotic Ultrasound System Uncovers Possible Breakthrough in Mechanically Ventilated COVID-19 Patients
Tests to Detect Common Immune Signature in Blood of COVID-19 Patients Could Predict Severity of Disease
Harvard Scientists Develop Broadly Deployable Biomaterials-Based Infection Vaccine Technology That Could Aid In COVID-19 Immunization
LumiraDx SARS-CoV-2 Antigen Test Granted FDA Emergency Use Authorization
Fitbit COVID-19 Study Finds Wearable Devices Can Identify Signs of Disease Before Symptoms Appear
